Inflammatory and immune-related proteins

Inflammatory and immune-related proteins encompass a diverse group of molecules, including cytokines, chemokines, receptors, and enzymes, that orchestrate the body's response to pathogens and tissue injury (StatPearls, 2023). These proteins, such as tumor necrosis factor-alpha (TNF-α) and various interleukins, act as signaling molecules that regulate the recruitment and activation of immune cells (NCBI, 2022). In healthy states, they facilitate host defense and wound healing; however, their chronic overproduction or dysregulation is a hallmark of autoimmune diseases, such as rheumatoid arthritis and inflammatory bowel disease, as well as systemic inflammatory conditions (PubMed, 2021). Therapeutic intervention often involves the use of monoclonal antibodies or small molecule inhibitors designed to neutralize specific proteins or block their respective receptors to restore immune homeostasis (NIH, 2023). Due to their central role in systemic signaling, targeting these proteins requires careful management to avoid excessive immunosuppression and increased susceptibility to infections (Nature Reviews Drug Discovery, 2020). This category also includes acute-phase reactants and complement system components that amplify the inflammatory cascade (Wikipedia, 2024). Many of these proteins serve as critical biomarkers for diagnosing disease activity and monitoring the efficacy of anti-inflammatory treatments (PubChem, 2023).

Other names

Immune system proteinsInflammatory mediatorsImmunomodulatory proteinsCytokines and chemokinesInflammatory markers

Varies by specific protein; includes neutralization of circulating ligands, competitive inhibition of cell-surface receptors, or inhibition of intracellular signaling pathways such as the JAK-STAT pathway (StatPearls, 2023).